Oxford Biomedica PLC Director/PDMR Shareholding (9513U)
January 24 2017 - 4:31AM
UK Regulatory
TIDMOXB
RNS Number : 9513U
Oxford Biomedica PLC
24 January 2017
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
1 Issuer Oxford BioMedica PLC
------ ------------------------ ----------------------------------
2 Reason for notification Notification relates to DTR
3.1.2R
------ ------------------------ ----------------------------------
3 Name of PDMR Martin Diggle
------ ------------------------ ----------------------------------
4 Connected person Notification relates to following
connected persons:
Vulpes Life Sciences Fund
------ ------------------------ ----------------------------------
5 Notification Notification in respect of
in respect of holdings of persons in 4 above
------ ------------------------ ----------------------------------
6 Description Oxford BioMedica PLC ordinary
of shares shares of 1p each
------ ------------------------ ----------------------------------
7 Name of registered Vulpes Life Sciences Fund
shareholders - 549,132,000 shares
and number of Vulpes Testudo Fund - 33,333,333
shares shares
------ ------------------------ ----------------------------------
8 Nature of transaction Acquisition
------ ------------------------ ----------------------------------
9 Number of shares Vulpes Life Sciences Fund
acquired - 600,000 shares
------ ------------------------ ----------------------------------
10 Percentage of Vulpes Life Sciences Fund
issued class - 0.02%
acquired
------ ------------------------ ----------------------------------
11 Shares disposed N/A
------ ------------------------ ----------------------------------
12 Percentage of N/A
issued class
disposed
------ ------------------------ ----------------------------------
13/14 Price per share Vulpes Life Sciences Fund
of transactions, 600,000 shares @ GBP0.0422
and date , 23 Jan 2017
------ ------------------------ ----------------------------------
15 Total holding Vulpes Life Sciences Fund
following notification - 549,732,000 shares
and total percentage 17.80%
holding following Vulpes Testudo Fund - 33,333,333
notification shares
1.08%
------ ------------------------ ----------------------------------
16 Date issuer 24 Jan 2017
informed
------ ------------------------ ----------------------------------
23 Any additional None
information
------ ------------------------ ----------------------------------
24 Contact name T. Watts, Chief Financial
and telephone Officer
number Oxford BioMedica
+44 (0)1865 783000
------ ------------------------ ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCGDBCDDBGRS
(END) Dow Jones Newswires
January 24, 2017 04:31 ET (09:31 GMT)
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024